Histone Deacetylase (hdac) Inhibitors - Cancer Science

Relevant Publications

Comprehensive analysis of microRNAs modulated by histone deacetylase inhibitors identifies microRNA-7-5p with anti-myeloma effect.

Issue Release: 2024

Epigenetic Aging in Major Depressive Disorder: Clocks, Mechanisms and Therapeutic Perspectives.

Issue Release: 2024

Biophysical insights into the dimer formation of human Sirtuin 2.

Issue Release: 2024

An drug repurposing approach to identify HDAC1 inhibitors against glioblastoma.

Issue Release: 2024

Induction of indoleamine 2,3-dioxygenase 1 expression in neurons of the central nervous system through inhibition of histone deacetylases blocks the progression of experimental autoimmune encephalomyelitis.

Issue Release: 2024

HDAC Inhibition Increases CXCL12 Secretion to Recruit Natural Killer Cells in Peripheral T Cell Lymphoma.

Issue Release: 2024

Investigating neuroepigenetic alterations in chronic low back pain with positron emission tomography.

Issue Release: 2024

Randomized phase 2 study of valproic acid combined with simvastatin and gemcitabine/nab-paclitaxel-based regimens in untreated metastatic pancreatic adenocarcinoma patients: the VESPA trial study protocol.

Issue Release: 2024

Hydrazide-Based Class I Selective HDAC Inhibitors Completely Reverse Chemoresistance Synergistically in Platinum-Resistant Solid Cancer Cells.

Issue Release: 2024

Transcriptomic heterogeneity of EGFR-mutant non-small cell lung cancer evolution towards small cell lung cancer.

Issue Release: 2024

Current and future therapeutic strategies for high-grade gliomas leveraging the interplay between epigenetic regulators and kinase signaling networks.

Issue Release: 2024

Novel multi-target angiogenesis inhibitors as potential anticancer agents: Design, synthesis and preliminary activity evaluation.

Issue Release: 2024

Nuclear KRT19 is a transcriptional co-repressor promoting histone deacetylation and liver tumorigenesis.

Issue Release: 2024

SIRT1 mediates breast cancer development and tumorigenesis controlled by estrogen-related receptor β.

Issue Release: 2024

Systemic histone deacetylase inhibition ameliorates the aberrant responses to acute stress in socially isolated male mice.

Issue Release: 2024

Chemical Versatility in Catalysis and Inhibition of the Class IIb Histone Deacetylases.

Issue Release: 2024

Development of a tetrahydroindazolone-based HDAC6 inhibitor with in-vivo anti-arthritic activity.

Issue Release: 2024

Molecular Targets of Valeric Acid: A Bioactive Natural Product for Endocrine, Metabolic, and Immunological Disorders.

Issue Release: 2024

Exploration of novel hydroxamate zinc binding group inhibitors against HDAC-1-3 enzymes by AI-based virtual screening: atomistic insights from steered molecular dynamics.

Issue Release: 2024

Is Psychological Support Accessible for All Cancer Patients?

Why is Coping Important?

What Materials Are Used in Sustainable Packaging?

Why is Esophageal Dilation Needed in Cancer Patients?

Who are the Key Healthcare Professionals in Cancer Care?

What is Quality Risk Management in Cancer Care?

How Can Support Systems Help Cancer Patients?

Can Supplements Help During Cancer Treatment?

What Challenges Might Arise During IPT for Cancer Patients?

How Does Ultrasound Imaging Work?

Histone Deacetylase (hdac) Inhibitors - Cancer Science

Relevant Publications

Partnered Content Networks

Relevant Topics